AlQahtani, Manaf
Kumar, Nitya
Aljawder, Dhuha
Abdulrahman, Abdulkarim
Mohamed, Mohammed Wael
Alnashaba, Fatema
Fayyad, Mohammed Abu
Alshaikh, Faisal
Alsahaf, Fatima
Saeed, Sawsan
Almahroos, Amal
Abdulrahim, Zainab
Otoom, Sameer
Atkin, Stephen L.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
https://doi.org/10.1038/s41598-022-08794-w
Article History
Received: 12 July 2021
Accepted: 7 February 2022
First Online: 23 March 2022
Change Date: 26 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-20899-w
Competing interests
: The authors declare no competing interests.